|Title:||Pulmonary Findings in Patients Post Mild/Moderate COVID-19|
|Author(s):||S. Navarro, H. Dias, J. Oliveira, L. Courtney, M. Nagle, A. Jahangir, A. Mulgrew|
|Institution:||Bon Secours Hospital - Tralee|
|Poster:||Click to view poster|
|Abstract:||On March 2020, the World Health Organization declared coronavirus disease 2019 (COVID-19) as a pandemic. There is little knowledge related to alterations in pulmonary function in Post COVID-19 patients.|
In the Respiratory Department at the Bon Secours Hospital Tralee, we carried out a retrospective study on 38 subjects diagnosed with Mild/Moderate COVID-19 Infection. From January to June 2021, Pulmonary Function Tests (PFT) were performed at least 30 days after diagnosis of COVID-19. D-Dimers, Protein C-Reactive, radiological changes and bronchoscopy data were also documented. Our objective was to determine the prevalence of PFT abnormalities in subjects diagnosed with COVID-19.
We present our experience of a growing data set of patients Post COVID-19. From the 38 subjects, 24 were female and 14 male with a mean age of 47 years old. The PFTs were performed in all subjects with an average time of 92 days after COVID-19 diagnosis.
Of 38 patients, 26% (N=10) of them had PFT abnormalities. 5 of these patients had pre-existing lung disease but there were no significant changes in PFT values Pre and Post COVID-19. The remaining 5 patients (13% of total number) without prior PFTs appeared to have abnormalities in lung function after COVID-19.